These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Yoo HY, Edwin D, Thuluvath PJ. Am J Gastroenterol; 2003 Jun; 98(6):1395-9. PubMed ID: 12818287 [Abstract] [Full Text] [Related]
45. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. Scand J Gastroenterol; 2009 Jun; 44(3):346-57. PubMed ID: 18991165 [Abstract] [Full Text] [Related]
46. Overview of the MELD score and the UNOS adult liver allocation system. Martin AP, Bartels M, Hauss J, Fangmann J. Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345 [Abstract] [Full Text] [Related]
47. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL. Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709 [Abstract] [Full Text] [Related]
49. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G. Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864 [Abstract] [Full Text] [Related]
51. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore. Lee YM, Fernandez M, Da Costa M, Lee KH, Sutedja DS, Tai BC, Tan KC, Isaac J, Prabhakaran K, Lim SG. Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430 [Abstract] [Full Text] [Related]
53. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Xiol X, Gines P, Castells L, Twose J, Ribalta A, Fuentes-Arderiu X, Rodriguez S, Castellote J, Navasa M, Deulofeu R. Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993 [Abstract] [Full Text] [Related]
54. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation. Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, Szymanik B, Jarosz K, Wójcicki M, Milkiewicz P. Transplant Proc; 2009 Oct; 41(8):3114-6. PubMed ID: 19857689 [Abstract] [Full Text] [Related]
55. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus]. Mun BS, Ahn HS, Ahn DS, Lee SO. Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750 [Abstract] [Full Text] [Related]
56. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ. Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555 [Abstract] [Full Text] [Related]
59. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience. de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-Vivaldi R, Alonso M. Transplantation; 2006 Dec 15; 82(11):1429-35. PubMed ID: 17164713 [Abstract] [Full Text] [Related]